SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001341004-20-000228
Filing Date
2020-05-27
Accepted
2020-05-27 16:23:22
Documents
3
Period of Report
2020-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6-k.htm 6-K 14803
2 EXHIBIT 99.1 - ADVANZ PHARMA CORP. LIMITED CLOSES ACQUISITION OF SPECIALTY PHARM ex99-1.htm EX-99.1 25892
3 image0.jpg GRAPHIC 72182
  Complete submission text file 0001341004-20-000228.txt   141376
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 20915491
SIC: 2834 Pharmaceutical Preparations